Home
About Us
As medical marijuana becomes more widely available in the US, one Canadian company is looking to take advantage.
Mydecine Innovations Group Inc.
has entered into subscription agreements with third-party investors to raise up to $3,750,000 through the sale of up to 18,750,000 common shares at a price of $0.20 per share, per a press release.
The company expects to close the deal on or about Sept.
16, 2023, per the release.
Mydecine, which is based in Vancouver, is a biotechnology company "engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and PTSD," per the release.
Mydecine's lead product is MYCO-006, an analogue of the active ingredient in marijuana known as MDMA, or ecstasy, that has been shown to be effective in treating pain, anxiety, depression, addiction, and post-traumatic stress disorder, among other conditions.
Mydecine's CEO, Joshua Bartch, tells the CBC that the company's research and development team is working with artificial intelligence to create medications that are affordable to the general public upon FDA and Health Canada approval.
(New York Gov.
Andrew Cuomo has signed a bill making recreational marijuana legal in the state.
Selected Grant News Headlines
A customized collection of grant news from foundations and the federal government from around the Web.
When the Marianas Alliance of Non-Governmental Organization (MANGO) reached out to the Rotary Club of Saipan, it wanted to make sure the club knew about its "cool" and "sustainable" development...more
One of the nation's largest not-for-profit health systems is launching a new company that it says will help doctors more effectively manage the care of patients with chronic conditions, the Los...more
When Brooklyn Hawkins rang the bell as a newly cancer-free 17-year-old, she was also trying to imagine her future. "I knew there was a bigger picture," the Oklahoma State University sophomore...more
An Indiana nonprofit that teaches kids how to make art is now open in a brick-and-mortar location, the Times of Northwest Indiana reports. "This was my mission, from the very beginning, to bring...more
If you're in Milwaukee and craving a snack or a bite to eat while you wait for the school day to start, you'll soon be able to do just that. The city's ThriveOn Collaboration has partnered with...more
Florida's IMA Medical Group is trying to do something that's never been done before: use artificial intelligence to improve the health of its own patients. The not-for-profit health system is...more
When it comes to fundraising, it's all about the numbers. But when it comes to data, it's all about " cultivating data excellence." That's what Forbes is calling the next big thing in...more
In an effort to " amplify the company's positive impact on the world," contract services firm Zeal has launched a new philanthropic armZeal Goodthat will match donations made by its employees,...more
"We want to highlight two members of the Safety and Health team who have helped in the implementation and management of recent key technologies." Those are the words of Mona Legin, a safety...more
When Washington state's Climate Commitment Act was passed in 2010, it was seen as a more business-friendly way to curb greenhouse gas emissions than stricter environmental standards. But a...more
Social Entrepreneurship
Spotlight
Social Enterprise Gets Investment Boost
Founder of the Eden Project, Sir Tim Smit, supported the Yorkshire Venture Philanthropy (YVP) investment program launch, which is designed to improve funding in social enterprises within the region.
